4 results about "Cynanchum" patented technology

The utility model relates to the technical field of field green prevention and control, in particular to a winter cnidium monnieri seedling raising device which comprises two half cylinders which are identical in shape and symmetrically arranged, the bottoms of the half cylinders are connected through a flexible belt, and the two half cylinders form a seedling raising cup structure with the top open and the bottom closed through the flexible belt in a butt joint state. The cnidium monnieri seedling raising device is simple in structure, the cnidium monnieri rhizosphere soil, namely the nutrient soil, is effectively wrapped by the opening and closing type seedling raising cup matched with the mesh bag structure, the transplanting effect is completed, and the transplanting survival rate of cnidium monnieri is ensured.

The application discloses a method for rooting induction of Cynanchum coccineum Schneid. tissue culture seedlings, and comprises the following steps: inoculating Cynanchum coccineum Schneid. tissue culture seedlings into MS modified culture medium to obtain sterile seedlings; inoculating the sterile seedlings into a proliferation culture medium for proliferation culture for 28-35 days to obtain adventitious bud clusters; inoculating the adventitious bud clusters into a rooting induction culture medium for rooting induction to obtain Cynanchum coccineum Schneid. seedlings; wherein the MS modified culture medium is a basic culture medium added with 0.1-0.2 g / L of activated carbon; the proliferation culture medium is a basic culture medium added with 0.2-1.0 mg / L of IBA, 0.1-0.5 mg / L of IAA and 0.3-1.0 mg / L of 6-BA; and the rooting induction culture medium is a basic culture medium added with 0.5-2.0 mg / L of NAA or 0.5-2.0 mg / L of IBA. The application can quickly induce Cynanchum coccineum Schneid. seedlings, and solves the problems of rooting difficulty and introduction and cultivation difficulty of Cynanchum coccineum Schneid. tissue culture.

The application discloses a traditional Chinese medicine composition for treating nodular erythema, which is prepared from the following raw materials in a proportion by weight: 3-15 parts of Bupleurum, 3-20 parts of Artemisia annua, 3-15 parts of Angelica sinensis, 3-15 parts of Radix Angelicae Pubescentis, 3-20 parts of Cynanchum, 3-15 parts of Notopterygium, 3-20 parts of Fructus Kochiae, 3-15 parts of Cnidium, 3-20 parts of Alnus, 3-10 parts of Glycyrrhiza, 3-20 parts of Salvia miltiorrhiza, 3-15 parts of Saposhnikovia divaricata, 3-15 parts of Paeonia suffruticosa, 3-10 parts of honeycomb, 3-12 parts of Tripterygium wilfordii, 5-30 parts of Crataegus pinnatifida, and 5-30 parts of Sorsastrum hemningsii. The composition can fade the skin rash and nodular erythema, has a low recurrence rate, and is superior to methylprednisolone which is commonly used in the clinic. The application can effectively treat the nodular erythema related to connective tissue disease, and has the clinical popularization and application value.

This invention provides a composition for treating post-infectious cough, prepared from the following raw materials in the indicated weight ratios: Ephedra 6-15 parts, Apricot Kernel 5-18 parts, Platycodon Root 8-21 parts, Cynanchum Root 8-19 parts, Aster Root 10-22 parts, Stemona Root 9-21 parts, Inula Flower 8-18 parts, Coltsfoot Flower 7-20 parts, Bamboo Shavings 10-21 parts, Scutellaria Root 12-21 parts, Oroxylum Root 4-16 parts, Belamcanda Rhizome 12-19 parts, Tangerine Peel 10-24 parts, Poria Cocos 9-22 parts, and Licorice Root 5-16 parts. This composition is precisely formulated and effectively relieves cough and phlegm, showing superior efficacy compared to the commonly used Western medicine dextromethorphan hydrobromide. It provides a better option for the clinical treatment of post-infectious cough and has promising application prospects.